Incorporating biological molecular interactions into cognitive computing through chemical artificial intelligence (AI) presents a transformative approach with far-reaching implications for various fields, such as protein engineering, drug discovery, bioinformatics, synthetic biology, and unconventional computing. Cognitive computing, designed to emulate human thought processes and enhance decision-making, utilizes technologies, such as machine learning, natural language processing, and speech recognition for better human-system interactions. Despite advancements, the integration of biological processes with cognitive computing remains fraught with challenges, particularly due to the complexity and scale of biological data. Here, we explore the possible benefits of connecting cognitive computing with biological knowledge, including more precise models of protein interactions, gene regulation, and metabolic pathways, which could lead to personalized treatments and early disease detection. Furthermore, we discuss the intersection of cognitive computing and biophysical research techniques, examining how analogies from neuroscience-like synaptic communication and neural plasticity-can inform the development of neuromorphic chips and enhance predictive models. Additionally, the study delves into intrinsically disordered proteins (IDPs) and their crucial roles in brain function and information processing. These insights are pivotal for advancing neuroinformatics and creating more adaptive, context-aware cognitive computing algorithms. By leveraging biophysical investigations and the unique properties of IDPs, the research aims to bridge the gap between the biological processes and their computational analogs, proposing novel methods, such as chemical AI implemented in liquid solutions as promising avenues for future advancements.
Keywords: Artificial intelligence; Cognitive computing; Intrinsically disordered proteins.
© International Union for Pure and Applied Biophysics (IUPAB) and Springer-Verlag GmbH Germany, part of Springer Nature 2025. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.